The Real-World Efficacy and Safety of Anlotinib Treatment for Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Wang, F. [1 ]
Jin, F. [1 ]
Wang, S. [1 ]
Zhu, Y. [1 ]
机构：
[1] Peking Univ, Dept Oncol, Shenzhen Hosp, Shenzhen, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P86.04
引用
收藏
页码：S673 / S673
页数：1
相关论文
共 50 条
  • [31] The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
    Zheng, Hao-Ran
    Jiang, Ai-Min
    Gao, Huan
    Liu, Na
    Zheng, Xiao-Qiang
    Fu, Xiao
    Zhang, Rui
    Ruan, Zhi-Ping
    Tian, Tao
    Liang, Xuan
    Yao, Yu
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2273 - 2287
  • [32] Real-world data on nivolumab treatment of non-small cell lung cancer
    Brustugun, O. T.
    Sprauten, M.
    Helland, A.
    [J]. ACTA ONCOLOGICA, 2017, 56 (03) : 438 - 440
  • [33] EFFICACY AND SAFETY OF ANLOTINIB COMBINED WITH ICOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG CANCER
    Chen, Hualin
    Luo, Yiping
    Lin, Muwen
    Peng, Xiaoxia
    Liu, Meilian
    Huang, Zhong
    Wang, Yongcun
    Li, Shujun
    Yang, Donghong
    Yang, Zhixiong
    [J]. ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 2035 - 2040
  • [34] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
  • [35] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
  • [36] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    [J]. TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
  • [37] Sex influence on cancer immunotherapy efficacy and safety in advanced non-small cell lung cancer (NSCLC): A Canadian institution real-world experience
    Cohen, Sara Frida
    Cruiziat, Diane
    Naimer, Jeremy
    Cohen, Victor
    Kasymjanova, Goulnar
    Spatz, Alan
    Agulnik, Jason Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
    Thakrar, D. B.
    Essang, B.
    Echlin, A.
    Murdock, C.
    Lind, M. J.
    [J]. LUNG CANCER, 2019, 127 : S40 - S41
  • [39] Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study
    Cavaille, Francois
    Peretti, Mathieu
    Garcia, Marie Eve
    Giorgi, Roch
    Ausias, Nathalie
    Vanelle, Patrice
    Barlesi, Fabrice
    Montana, Marc
    [J]. TUMORI JOURNAL, 2021, 107 (01): : 32 - 38
  • [40] Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
    Hozefa A. Divan
    Marisa A. Bittoni
    Ashok Krishna
    David P. Carbone
    [J]. BMC Cancer, 24
12345